Sereti I, Dunham RM, Spritzler J, Aga E, Proschan MA, Medvik K, et al. IL-7 administration drives T cell-cycle entry and expansion i n HIV -1 infection. Blood 113, 6304 –6314 (2009). Sereti I, Estes J, Thompson W, Fischl M, Croughs T, Beq S, Yao M, Boulassel MR, Lederman MM, Routy J-P. Gut Mucosa T Lymphocyte Restoration in Chronically HIV -Infected Patients Treated with Recombinant Huma Interleukin -7 (rhIL -7). Conference on Retrovirus and Opportunistic Infections, Seattle, WA (March 2012). Sheikh NA, De La Rosa CP, Kuan L, Stewart FP, Frohlich MW, Urdal DL, et al. Sipuleucel -T treatment results in sequential ex vivo activation of APCs and T cells during the culture step —evidence for in vivo immunological priming [abstract]. In: Proceedings of the 101st Annual Meeting of the America n Association for Cancer Research; 2010 Apr 17 –21; Washington, DC.